News Archive
Remembering Carl Woese through the Undergraduate Research Scholar Program
Ananya Sen
Every summer, the Carl R. Woese Undergraduate Research Scholar Program helps students conduct research on a full-time basis over the summer.
Joseph Fernandez
Ananya Sen
Joseph Fernandez is a postdoctoral researcher at the Genomics and Eco-evolution of Multi-Scale Symbioses Institute at the University of Illinois Urbana
Donor Spotlight: Aarush M. Patel Foundation
Shelby Lawson
In 2018, Mitul Patel and his wife, Aditi Patel, got married and were looking to start a family when they first experienced issues with infertility.
Ratna Karatgi
Shelby Lawson
Investigating mechanisms behind variation in color of killifish
Lisa Surber
Shelby Lawson
Studying behavioral and morphological responses to environmental cues in poison frogs
Kathure Mugambi
Ananya Sen
Kathure Mugambi is a senior undergraduate student in Molecular and Cellular Biology. She is also the undergraduate assistant for the IGB Lunchbox series.
Bioethicist Françoise Baylis to give IGB Distinguished Public Lecture in Genomics
Françoise Baylis, PhD, Distinguished Research Professor Emerita at Dalhousie University, will speak as part of the IGB Distinguished Public Lecture in Genomics series at 4:00 p.
Young Innovator Program Spotlight: Jason Wang
Ananya Sen, Shelby Lawson
Jason Wang, a graduate student in the Kong (GNDP/M-CELS) lab, won third place in the 2022 Young Innovator program and received $5000 to advance his proposal.
Young Innovator Program Spotlight: Skye Shepard
Ananya Sen, Shelby Lawson
Skye Shepherd is a graduate student in the Cunningham (CGD/MMG) group, where she develops new detection tools for proteins that can be used to identify diseases including cancer
Young Innovator Program Spotlight: Alejandra Zeballos
Ananya Sen, Shelby Lawson
Alejandra Zeballos works on creating new therapies for neurological disorders.
Kathy Millage
Ananya Sen
Kathy Millage is an Office Administrator at the IGB.
Erik Nelson: A milestone in my career
Christine des Garennes
Several days following the Federal Drug Administration’s approval of a new cancer drug, Erik Nelson (A